-
11987-100A third generation aromatase inhibitor that blocks the conversion of androgens to estrogens in peripheral tissues (IC50 = 15 nM in human placenta in vitro) without interfering with cholesterol, cortisol, or aldosterone biosynthesis used to treat
-
11987-50A third generation aromatase inhibitor that blocks the conversion of androgens to estrogens in peripheral tissues (IC50 = 15 nM in human placenta in vitro) without interfering with cholesterol, cortisol, or aldosterone biosynthesis used to treat
-
18772-10A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.
-
18772-25A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.
-
18772-5A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.
-
18772-50A non-steroidal SARM that has tissue-selective androgenic and anabolic effects in animals improves muscle strength and prevents bone loss in orchidectomized rats.
-
B3209-100 mg
Thomas Scientific
Androgen receptor antagonist used to treat prostate cancer a (C08-0488-603)
Price: $164.05List Price: $182.28Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth of -
B3209-250 mg
Thomas Scientific
Androgen receptor antagonist used to treat prostate cancer a (C08-0488-815)
Price: $244.12List Price: $271.25Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth of -
B3210-100 mg
Thomas Scientific
Androgen receptor antagonist used to treat prostate cancer a (C08-0489-215)
Price: $398.46List Price: $442.73R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth -
B3209-1 g
Thomas Scientific
Androgen receptor antagonist used to treat prostate cancer a (C08-0489-474)
Price: $601.37List Price: $668.19Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth of -
B3210-250 mg
Thomas Scientific
Androgen receptor antagonist used to treat prostate cancer a (C08-0489-542)
Price: $674.04List Price: $748.93R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth -
B3210-1 g
Thomas Scientific
Androgen receptor antagonist used to treat prostate cancer a (C08-0489-859)
Price: $1,914.93List Price: $2,127.70R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth